glp 1 and hypothyroidism The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care Patients Who Lose Weight After

pharmaceutical landscape, GLP-1 medications have surged to blockbuster status, driven by soaring demand for both diabetes management and weight loss solutions

The most undertreated chronic disease: Addressing obesity in primary care settings

Altimmune will meet with the Food and Drug Administration in the second half of the year to chart a path forward for the injection

However, real-life analyses indicate a higher discontinuation rate, of approximately 70% stopping within 2 years, especially in non-diabetic patients (112, 113)

When you eat, GLP-1 is released into your bloodstream, where it performs several vital functions that influence how your body processes food and manages energy

While clinical trials show an average weight loss of 10.2%, in reality, some people lose over 25% of their body weight, while 32.2% lose less than 5% or even gain weight